Overexpression of human BAG3<sup>P209L</sup> in mice causes restrictive cardiomyopathy.

Kimura, Kenichi; Ooms, Astrid; Graf-Riesen, Kathrin; Kuppusamy, Maithreyan; Unger, Andreas; Schuld, Julia; Daerr, Jan; Lother, Achim et al. · Nat Commun · 2021

basic_science · Level V

Where this comes from

Abstract

An amino acid exchange (P209L) in the HSPB8 binding site of the human co-chaperone BAG3 gives rise to severe childhood cardiomyopathy. To phenocopy the disease in mice and gain insight into its mechanisms, we generated humanized transgenic mouse models. Expression of human BAG3<sup>P209L</sup>-eGFP in mice caused Z-disc disintegration and formation of protein aggregates. This was accompanied by massive fibrosis resulting in early-onset restrictive cardiomyopathy with increased mortality as observed in patients. RNA-Seq and proteomics revealed changes in the protein quality control system and increased autophagy in hearts from hBAG3<sup>P209L</sup>-eGFP mice. The mutation renders hBAG3<sup>P209L</sup> less soluble in vivo and induces protein aggregation, but does not abrogate hBAG3 binding properties. In conclusion, we report a mouse model mimicking the human disease. Our data suggest that the disease mechanism is due to accumulation of hBAG3<sup>P209L</sup> and mouse Bag3, causing sequestering of components of the protein quality control system and autophagy machinery leading to sarcomere disruption.

Medical subject headings